tert-Butyl 4-(2,2-dibromovinyl)piperidine-1-carboxylate

Catalog No. :
ACJQWF421
CAS No. :
203664-61-3
Molecular Formula :
C12H19Br2NO2
Molecular Weight :
369.10

IUPAC Name:tert-butyl 4-(2,2-dibromovinyl)piperidine-1-carboxylate

tert-Butyl 4-(2,2-dibromovinyl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$242.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(2,2-dibromovinyl)piperidine-1-carboxylate
IUPAC Nametert-butyl 4-(2,2-dibromovinyl)piperidine-1-carboxylate
MDL No.MFCD20528891
Molecular FormulaC12H19Br2NO2
Molecular Weight369.10
SMILESO=C(N1CCC(C=C(Br)Br)CC1)OC(C)(C)C
InChI KeyMBNHUCDXSFFRLG-UHFFFAOYSA-N
Synonymtert-butyl 4-(2,2-dibroMovinyl)piperidine-1-carboxylate;tert-butyl 4-(2,2-dibromoethenyl)piperidine-1-carboxylate;4-(2,2-dibromoethenyl)-1-piperidinecarboxylic acid tert-butyl ester;4-(2,2-dibromo-vinyl)-piperidine-1-carboxylic acid tert-butyl ester;1-Piperidinecarboxylic acid, 4-(2,2-dibromoethenyl)-, 1,1-dimethylethyl ester
CAS No.203664-61-3
PubChem CID11474132

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACJQWF421 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTNLC596 route compound structure diagram
    ACTNLC596137076-22-3
  4. Then
  5. ACJQWF421 route product structure diagram
    ACJQWF421203664-61-3
Inquiry

2. ACJQWF421 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTNLC596 route compound structure diagram
    ACTNLC596137076-22-3
  2. Then
  3. ACJQWF421 route product structure diagram
    ACJQWF421203664-61-3
Inquiry

Comments (0)